Analysts expect Syndax Pharmaceuticals Inc to report revenue of 88.52 M for Q3 26, against a range of 81.20 M to 95.83 M. The most recent reported quarter, Q2 26, came in at 72.79 M, a 11.2% miss against the 81.95 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 12.50 M | 7.68 M | 20.04 M | 37.96 M | 45.87 M | 68.73 M | 64.86 M | 72.79 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 9.03 M | 35.44 M | 16.10 M | 27.94 M | 49.16 M | 74.25 M | 77.47 M | 88.39 M | 95.83 M | 106.97 M | 102.70 M | 122.41 M | 132.80 M | 148.33 M | 144.51 M | 176.05 M | ||||||||||
| Low Estimate | 8.35 M | 30.75 M | 14.55 M | 23.47 M | 40.79 M | 63.19 M | 69.99 M | 75.50 M | 81.20 M | 96.21 M | 93.00 M | 106.17 M | 116.88 M | 129.40 M | 128.27 M | 147.38 M | ||||||||||
| Consensus Estimate | 8.69 M | 33.09 M | 15.32 M | 25.71 M | 44.98 M | 68.72 M | 73.73 M | 81.95 M | 88.52 M | 101.59 M | 97.85 M | 114.29 M | 124.84 M | 138.87 M | 136.39 M | 161.72 M |
Analysts expect Syndax Pharmaceuticals Inc to report earnings per share of -0.44 for Q3 26, against a range of -0.47 to -0.41. The most recent reported quarter, Q2 26, came in at -0.55, a 27.9% miss against the -0.43 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.98 | -1.10 | -0.98 | -0.83 | -0.70 | -0.78 | -0.48 | -0.55 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.04 | -0.83 | -1.05 | -0.93 | -0.64 | -0.56 | -0.58 | -0.42 | -0.41 | -0.41 | -0.07 | -0.16 | -0.13 | -0.15 | 0.16 | 0.11 | ||||||||||
| Low Estimate | -1.20 | -0.91 | -1.29 | -1.05 | -0.76 | -0.66 | -0.70 | -0.44 | -0.47 | -0.49 | -0.07 | -0.20 | -0.15 | -0.17 | 0.14 | 0.09 | ||||||||||
| Consensus Estimate | -1.12 | -0.87 | -1.17 | -0.99 | -0.70 | -0.61 | -0.64 | -0.43 | -0.44 | -0.45 | -0.07 | -0.18 | -0.14 | -0.16 | 0.15 | 0.10 |
Pull Wall Street consensus for Syndax Pharmaceuticals Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SNDX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SNDX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SNDX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();